Features

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores the roots of...

“It really is about having a dream and figuring out how to go about accomplishing that dream”

Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders...

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI and big data are...

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout her teens, Niamh ni Ruari...

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done to improve the way...

Nick Stephens of the RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life sciences, and...

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had generated millions in savings by...

Just as his company announced robust H1 2018 financials, UCB's Jean-Christophe Tellier spoke to Pharmafocus to share his experiences of the tough...

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and...